Meeting: 2018 ASCO Annual Meeting Track: Genitourinary (Nonprostate) Cancer Abstract number: 4511 Authors: Bernard Escudier, Robert J. Motzer, Brian I. Rini, et. al. Background: The randomized, open-label Phase III IMmotion151 study met its coprimary endpoint in PD-L1+ patients (pts) with improvement in investigator-assessed PFS for atezo + bev vs sun (HR...
Pro zobrazení tohoto obsahu je třeba být přihlášen.